Heparin interacts with elongation factor 1α of Cryptosporidium parvum and inhibits invasion

Atsuko Inomata1, Fumi Murakoshi2, Akiko Ishiwa2

  • 1Department of Veterinary Microbiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.

Scientific Reports
|July 2, 2015
PubMed

Insights

Sulfated polysaccharides, particularly heparin, inhibit Cryptosporidium parvum invasion of host cells. Researchers identified parasite protein CpEF1α as a key molecule interacting with heparin, offering potential for new anti-cryptosporidial therapies.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Cryptosporidium parvum causes watery diarrhea (cryptosporidiosis) in mammals.
  • Parasite invasion involves host cell surface glycosaminoglycans, but interactions are poorly understood.

Purpose of the Study:

  • To investigate the inhibitory effects of sulfated polysaccharides on C. parvum invasion.
  • To identify parasite ligands that bind to sulfated polysaccharides.

Main Methods:

  • Screening five sulfated polysaccharides for inhibitory activity against C. parvum invasion.
  • Utilizing heparan sulfate-deficient cells to assess infection susceptibility.
  • Identifying potential parasite-heparin binding proteins using proteomic approaches.
  • Confirming binding of C. parvum elongation factor 1α (CpEF1α) to heparin and host cells.

Main Results:

  • Heparin demonstrated the most potent, dose-dependent inhibition of C. parvum invasion.
  • Heparan sulfate-deficient cells showed reduced susceptibility to infection.
  • Thirty-one parasite proteins potentially interacting with heparin were identified.
  • CpEF1α was confirmed to bind heparin and the surface of HCT-8 host cells, playing a role in invasion.

Conclusions:

  • Sulfated polysaccharides, especially heparin, can block C. parvum host cell invasion.
  • CpEF1α is a novel parasite ligand that interacts with host cell surface molecules.
  • Findings advance understanding of C. parvum infection mechanisms and suggest therapeutic targets.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
52